We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Injectable Gel Solidifies into a Therapeutic Matrix

By HospiMedica staff writers
Posted on 16 Apr 2007
A new study describes a polysaccharide-based hydrogel, designed to be injected into the spinal cord and other tissues, which forms a three-dimensional (3D) matrix that eventually disintegrates as it is replaced by healthy tissue. More...


The new material, developed by researchers at Purdue University (West Lafayette, IN; USA) and Arizona State University (ASU; Tempe, AZ, USA) mimics an extracellular matrix (ECM) environment. By attaching the polysaccharide-binding peptides (PBP) from antithrombin III to a synthetic material called polyethylene glycol, the basic hydrogel is formed. Mixing this peptide-polyethylene glycol combination with heparin--a natural polysaccharide--instantly solidifies it into a 3D matrix.

The scientists have also shown how gels are strengthened by using polymers that have more functional groups--segments that attach to other molecules to fortify the matrix by forming crosslinks from one molecule to the next. This crosslinking can be used to strengthen the matrix about 10 times, which could be compared to raising consistency of the gel from that of mayonnaise to something closer to that of cartilage. The gel can also be loaded with time-released therapeutic drugs, such as growth factors used in wound healing, bone regeneration, and other medical applications. This same approach could be used to improve drug-eluting stents, making them less prone to clot formation. The study was presented at the American Chemical Society's national meeting, held during March 2007 in Chicago (IL, USA).

"It is thought that most of the damage caused in spinal cord injury is not caused by the initial injury but by the inflammation that occurs later,” said lead author Dr. Alyssa Panitch, an associate professor of biomedical engineering at Purdue. "So, if you could inject this gel with a therapeutic agent that inhibits inflammation while secreting growth factors within several hours of injury that could potentially be very useful.”

Polysaccharide-based hydrogels have emerged as an intriguing biomaterial for tissue engineering due to their low immunologic response and the biologic importance of polysaccharides throughout the ECM in vivo. Within the ECM, polysaccharides associate with proteins to regulate cell adhesion, migration, and proliferation.


Related Links:
Purdue University
Arizona State University

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.